The need for standardization of antiretinal antibody detection and measurement.

Farzin Forooghian, Ian M Macdonald, John R Heckenlively, Elise Héon, Lynn K Gordon, John J Hooks, Barbara Detrick, Robert B Nussenblatt

Journal: American journal of ophthalmology 2008;146(4):489-95

PMID: 18672221

Abstract

PURPOSE

To review the current literature on the detection and measurement of antiretinal antibodies.

DESIGN

Collaborative essay.

METHODS

Literature review and interpretation.

RESULTS

There is strong evidence to suggest a role for antiretinal antibodies, particularly those targeting recoverin and alpha-enolase, in the pathogenesis of autoimmune retinopathy (AIR). Additionally, numerous other autoantibodies have been described as putative mediators of retinal degeneration and more remain to be discovered. However, assay methods described in the literature by many laboratories for the detection of circulating antiretinal antibodies have been varied and diverse, making it difficult to interpret and compare their results.

CONCLUSIONS

There is currently little standardization of laboratory methods used to detect and monitor antiretinal antibodies. To measure and monitor levels of circulating antiretinal antibodies optimally in patients with AIR, development of standardized assays with stringent internal controls is required. A multicenter collaborative and validation effort is encouraged to reach a consensus on this issue.

Address: Division of Epidemiology and Clinical Research, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.